These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

313 related articles for article (PubMed ID: 16952444)

  • 1. A comparative study of granzyme B expression in keratoacanthoma and squamous cell carcinoma.
    Batinac T; Zamolo G; Hadzisejdic I; Zauhar G
    J Dermatol Sci; 2006 Nov; 44(2):109-12. PubMed ID: 16952444
    [No Abstract]   [Full Text] [Related]  

  • 2. Cell apoptosis as assessed by M30 expression in keratoacanthoma and squamous cell carcinoma.
    Batinac T; Zamolo G; Brumini G; Biljan D; Petranović D; Troselj-Vukić B
    Coll Antropol; 2008 Jun; 32(2):499-504. PubMed ID: 18756900
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Subungual keratoacanthoma: analysis of cell proliferation and copy number variation of oncogenes compared with periungual squamous cell carcinoma.
    Honma M; Kato N; Hashimoto M; Takahashi H; Ishida-Yamamoto A; Iizuka H
    Clin Exp Dermatol; 2011 Jan; 36(1):57-62. PubMed ID: 20456385
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of cell cycle and apoptosis regulatory proteins in keratoacanthoma and squamous cell carcinoma.
    Batinac T; Zamolo G; Coklo M; Hadzisejdic I; Stemberger C; Zauhar G
    Pathol Res Pract; 2006; 202(8):599-607. PubMed ID: 16781827
    [TBL] [Abstract][Full Text] [Related]  

  • 5. VCAM (CD-106) and ICAM (CD-54) adhesion molecules distinguish keratoacanthomas from cutaneous squamous cell carcinomas.
    Melendez ND; Smoller BR; Morgan M
    Mod Pathol; 2003 Jan; 16(1):8-13. PubMed ID: 12527707
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The expression of p63 and p53 in keratoacanthoma and intraepidermal and invasive neoplasms of the skin.
    Sakiz D; Turkmenoglu TT; Kabukcuoglu F
    Pathol Res Pract; 2009; 205(9):589-94. PubMed ID: 19577853
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Squamous Cell Carcinoma Arising From Keratoacanthoma: An Evaluation by RT-PCR.
    Ni C; Su A; Ra S; Li X; Cochran A; Binder S
    Am J Dermatopathol; 2016 Mar; 38(3):247-9. PubMed ID: 26067455
    [No Abstract]   [Full Text] [Related]  

  • 8. Transforming growth factor alpha expression helps to distinguish keratoacanthomas from squamous cell carcinomas.
    Ho T; Horn T; Finzi E
    Arch Dermatol; 1991 Aug; 127(8):1167-71. PubMed ID: 1863074
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ectopic expression of Zmiz1 induces cutaneous squamous cell malignancies in a mouse model of cancer.
    Rogers LM; Riordan JD; Swick BL; Meyerholz DK; Dupuy AJ
    J Invest Dermatol; 2013 Jul; 133(7):1863-9. PubMed ID: 23426136
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Special nosological status of keratoacanthoma. Clinical, histological and comparative Feulgen-cytophotometric studies. 2. Clinical aspects of keratoacanthoma, discussion of Feulgen-cytophotometric findings].
    Ehlers G; Knoth W; Sandritter W
    Fortschr Med; 1976 Oct; 94(30):1732-5. PubMed ID: 992546
    [No Abstract]   [Full Text] [Related]  

  • 11. Apoptotic markers in the differential diagnosis of keratoacanthoma versus squamous cell carcinoma.
    Fernandez-Flores A
    Histopathology; 2007 Jan; 50(2):284-5. PubMed ID: 17222261
    [No Abstract]   [Full Text] [Related]  

  • 12. Expression of keratin and involucrin in keratoacanthoma: an immunohistochemical aid to diagnosis.
    Ichikawa E; Ohnishi T; Watanabe S
    J Dermatol Sci; 2004 Apr; 34(2):115-7. PubMed ID: 15033195
    [No Abstract]   [Full Text] [Related]  

  • 13. [Special nosological status of keratoacanthoma. Clinical, histological and comparative Feulgen-cytophotometric studies. 1. Examination material and methods, results].
    Ehlers G; Knoth W; Sandritter W
    Fortschr Med; 1976 Oct; 94(29):1623-9. PubMed ID: 992535
    [No Abstract]   [Full Text] [Related]  

  • 14. Expression of apoptosis-inducing factor (AIF) in keratoacanthomas and squamous cell carcinomas of the skin.
    Skyrlas A; Hantschke M; Passa V; Gaitanis G; Malamou-Mitsi V; Bassukas ID
    Exp Dermatol; 2011 Aug; 20(8):674-6. PubMed ID: 21410769
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Disorders of keratinisation.
    Stollery N
    Practitioner; 2007 Sep; 251(1698):60-5. PubMed ID: 17955881
    [No Abstract]   [Full Text] [Related]  

  • 16. Beta-catenin and CD44 expression in keratoacanthoma and squamous cell carcinoma of the skin.
    Tataroglu C; Karabacak T; Apa DD
    Tumori; 2007; 93(3):284-9. PubMed ID: 17679465
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Absence of somatic mutations of NEMO in keratoacanthoma.
    Ridd K; Vemula S; Bastian BC
    J Invest Dermatol; 2009 Oct; 129(10):2518-20. PubMed ID: 19404319
    [No Abstract]   [Full Text] [Related]  

  • 18. EGFR and MYC gene copy number aberrations are more common in squamous cell carcinoma than keratoacanthoma: a FISH study.
    Jacobs MS; Persons DL; Fraga GR
    J Cutan Pathol; 2013 May; 40(5):447-54. PubMed ID: 23521519
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of Cyclooxygenase-2 in Squamous Cell Carcinoma and Keratoacanthoma and its Clinical Significance.
    Hua HK; Jin C; Yang LJ; Tao SQ; Zhu XH
    Cell Biochem Biophys; 2015 Jun; 72(2):475-80. PubMed ID: 25575894
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanism of transepithelial elimination of elastic fibers in keratoacanthoma.
    Ohashi A; Ishizaki M; Kawana S; Fukuda Y
    Pathol Int; 2004 Aug; 54(8):585-94. PubMed ID: 15260849
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.